Palvella Therapeutics
Price & Volume
Stats
See more52W Range | $20.35-$151.18 |
Market Cap | $1.8B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.17 |
News
See moreYahoo Finance • 4 days ago
FDA Grants Rolling Review of Palvella’s QTORIN™ Rapamycin NDA for Microcystic Lymphatic Malformations
Yahoo Finance • 24 days ago
Palvella Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026
Yahoo Finance • last month
Palvella Therapeutics Announces Uplisting to the Nasdaq Global Market
Yahoo Finance • 2 months ago
Roivant Sciences Ltd. (ROIV): One of the Best Stocks to Buy According to Joe Edelman
About
CEO | Mr. Wesley H. Kaupinen |
CFO | Mr. Matthew E. Korenberg |
Address | 353 W. Lancaster Avenue, Wayne, PA, United States, 19087 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 29 |